This technology has allowed advancements in target therapies such as CART-cell therapy, which has shown promising results when used for cancer treatments.
This technology has allowed advancements in target therapies such as CART-cell therapy, which has shown promising results when used for cancer treatments. Last year we saw the FDA approval for Carvykti, the second therapy treatment approved for the later stages of blood cancer. We’ve also seen recent success in personalised therapies for diseases such as lupus, showing a promising and wider use of CAR-T cell therapy.